Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Lsm2em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Lsm2em1/Cya

Common Name
Lsm2-KO
Product ID
S-KO-08945
Backgroud
C57BL/6JCya
Strain ID
KOCMP-27756-Lsm2-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Lsm2-KO Mouse (Catalog S-KO-08945) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Lsm2-KO
Strain ID
KOCMP-27756-Lsm2-B6J-VA
Gene Name
Lsm2
Product ID
S-KO-08945
Gene Alias
G7b, SmX5, Dmapl, Sm-X5, snRNP, Dmpkap, D17H6S56E2, D17H6S56E-2
Background
C57BL/6JCya
Gene Full Name
LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated
Modification
Conventional knockout
NCBI ID
27756 (Mouse)
Phenotype
MGI:90676
Chromosome
Chr 17 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000007266
NCBI Transcript ID
NM_030597
Target Region
Exon 1~5
Size of Effective Region
~3.2 kb
Overview of Gene Research
Lsm2, a component of multiple Lsm protein complexes, is involved in RNA metabolism, such as mRNA decay, RNA splicing, and targeted RNA decay [4,5,6,7,8,9,10]. The Lsm2-8 complex binds and stabilizes the spliceosomal U6 snRNA, while Lsm2-7 associates with specific small nucleolar RNAs, contributing to their biogenesis or function [7,8,9,10]. These functions are crucial for normal cellular processes.

In disease-related research, Lsm2 has been implicated in various malignancies. In skin cutaneous melanoma (SKCM), high Lsm2 expression at both mRNA and protein levels is associated with a poor prognosis, promoting cell proliferation, migration, and invasion. Silencing Lsm2 in SKCM cells significantly inhibits these malignant behaviors [1]. In hepatocellular carcinoma (LIHC), Lsm2 is highly expressed, related to clinicopathological characteristics and poor prognosis, and knockdown of Lsm2 inhibits cell proliferation, migration, and invasion in vitro [3]. In COPD, Lsm2 is critical to club cell proliferation. Knocking down Lsm2 in vitro reduces cell viability, and knockout of Lsm2 in lungs or specifically in club cells exacerbates lung injury and inflammation caused by cigarette smoke exposure, accelerating COPD progression [2].

In conclusion, Lsm2 is essential for RNA-related cellular functions. Its role in promoting tumorigenesis in SKCM and LIHC, as well as its importance in club cell-related COPD progression, highlights the significance of Lsm2 in disease mechanisms. These findings from functional studies, including gene knockout-based research, provide insights into potential therapeutic targets for these diseases.

References:
1. Sun, Xiaofang, Zhang, Jianping, Hu, Jiayuan, Han, Qingdong, Ge, Zili. 2023. LSM2 is associated with a poor prognosis and promotes cell proliferation, migration, and invasion in skin cutaneous melanoma. In BMC medical genomics, 16, 129. doi:10.1186/s12920-023-01564-1. https://pubmed.ncbi.nlm.nih.gov/37312186/
2. Zhu, Wensi, Han, Linxiao, He, Ludan, Zhu, Qiaoliang, Zhou, Jian. 2025. Lsm2 is critical to club cell proliferation and its inhibition aggravates COPD progression. In Respiratory research, 26, 71. doi:10.1186/s12931-025-03126-8. https://pubmed.ncbi.nlm.nih.gov/40022153/
3. Qin, Peifang, Huang, Haitao, Wang, Jiahui, He, Yulin, Zhou, Yali. 2023. The mechanism of LSM2 in the progression of live hepatocellular carcinoma was analyzed based on bioinformatics. In Medical oncology (Northwood, London, England), 40, 276. doi:10.1007/s12032-023-02152-0. https://pubmed.ncbi.nlm.nih.gov/37612479/
4. Wu, Donghui, Muhlrad, Denise, Bowler, Matthew W, Parker, Roy, Song, Haiwei. 2013. Lsm2 and Lsm3 bridge the interaction of the Lsm1-7 complex with Pat1 for decapping activation. In Cell research, 24, 233-46. doi:10.1038/cr.2013.152. https://pubmed.ncbi.nlm.nih.gov/24247251/
5. Mattout, Anna, Gaidatzis, Dimos, Padeken, Jan, Kalck, Véronique, Gasser, Susan M. 2020. LSM2-8 and XRN-2 contribute to the silencing of H3K27me3-marked genes through targeted RNA decay. In Nature cell biology, 22, 579-590. doi:10.1038/s41556-020-0504-1. https://pubmed.ncbi.nlm.nih.gov/32251399/
6. Rahman, Naimur, Sun, Jiazeng, Li, Zhili, Aryal, Uma K, Andrisani, Ourania. 2022. The cytoplasmic LSm1-7 and nuclear LSm2-8 complexes exert opposite effects on Hepatitis B virus biosynthesis and interferon responses. In Frontiers in immunology, 13, 970130. doi:10.3389/fimmu.2022.970130. https://pubmed.ncbi.nlm.nih.gov/36016928/
7. Fernandez, Cesar F, Pannone, Barbara K, Chen, Xinguo, Fuchs, Gabriele, Wolin, Sandra L. 2004. An Lsm2-Lsm7 complex in Saccharomyces cerevisiae associates with the small nucleolar RNA snR5. In Molecular biology of the cell, 15, 2842-52. doi:. https://pubmed.ncbi.nlm.nih.gov/15075370/
8. Montemayor, Eric J, Virta, Johanna M, Hayes, Samuel M, Brow, David A, Butcher, Samuel E. 2020. Molecular basis for the distinct cellular functions of the Lsm1-7 and Lsm2-8 complexes. In RNA (New York, N.Y.), 26, 1400-1413. doi:10.1261/rna.075879.120. https://pubmed.ncbi.nlm.nih.gov/32518066/
9. Esteve-Bruna, David, Carrasco-López, Cristian, Blanco-Touriñán, Noel, Salinas, Julio, Alabadí, David. . Prefoldins contribute to maintaining the levels of the spliceosome LSM2-8 complex through Hsp90 in Arabidopsis. In Nucleic acids research, 48, 6280-6293. doi:10.1093/nar/gkaa354. https://pubmed.ncbi.nlm.nih.gov/32396196/
10. Roth, Allen J, Shuman, Stewart, Schwer, Beate. 2018. Defining essential elements and genetic interactions of the yeast Lsm2-8 ring and demonstration that essentiality of Lsm2-8 is bypassed via overexpression of U6 snRNA or the U6 snRNP subunit Prp24. In RNA (New York, N.Y.), 24, 853-864. doi:10.1261/rna.066175.118. https://pubmed.ncbi.nlm.nih.gov/29615482/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research